PLX Pharma (PLXP) bullish signal for a small Biotech as 1000 July $7.50 near-the-money puts sell to open at $1.85 to $1.60 showing confidence in a name at mutli-month lows and returning to early 2021 levels after reaching above $20 a few months ago. Ray-Jay out positive on 12/7 with a $14 target seeing its Vazalore asset as having $250M peak sales potential. PLXP has a market cap of $186M and trades 2.25X Cash. JMP has a $21 target noting strong Vazalore placement at 30K stores nationwide as well as e-retailers. Vazalore is an OTC liquid filled aspirin product and BWS Financial noted in September that PLXP is likely a target of a large Pharma Co.